Khadeeja Arshed*
Department of Biotechnology, Russia
*Corresponding Author: Khadeeja Arshed, Department of Biotechnology, Russia.
Received: April 12, 2024; Published: May 01, 2024
In the past, only nature could create pathogens. Through evolution, it demonstrated an impressive ability to produce a wide range of infectious agents. But now, thanks to advancements in biotechnology, humans can engineer new viruses and bacteria. Synthetic biology, in particular, offers exciting opportunities to better understand disease-causing agents and create new medical treatments and diagnostic tools. However, these advancements also bring the risk that some of the deadliest pathogens in history could be recreated without needing access to natural sources. Recombineering techniques are widely used in laboratories, but they do have some limitations. Recently, there have been many new genome-editing technologies emerging. One example is CRISPR, which has revolutionized the ability to edit the genetic code.
Citation: Khadeeja Arshed. “Dual Nature of Biotechnological Innovation".Acta Scientific Biotechnology 5.3 (2024): 01.
Copyright: © 2024 Khadeeja Arshed. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.